Researchers Link Menopause Treatment to Increased Lung Cancer Death Risk

by: cancercompass

Researchers have linked hormone replacement therapy to an increased risk of lung cancer, reports ABC News.

During the American Society of Clinical Oncology's annual meeting, Dr. Rowan Chlebowski of Harbor-UCLA Medical Center in Los Angeles said using estrogen and progestin leads to a 59% increase in death risk if women develops non-small cell lung cancer.

These findings are a part of the Women's Health Initiative, which originally linked hormone replacement therapy with increased risk of breast cancer, stroke and blood clots. Despite this, Dr. Chlebowski reports 15% of post menopausal women continue to use this therapy combination, which amounts to 25-30 million prescriptions written yearly.

Managing menopause symptoms without increasing cancer and stroke risk is difficult. Share your experience with alternative methods that work in reducing the many symptoms associated with menopause. Help breast cancer survivors, patients and their caregivers currently supporting one another at both the Cancer Compass Breast Cancer Message Board and the Lung Cancer Message Board.